Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v1-EN
Language English English
Date Updated 2024-08-07 2024-07-03
Drug Identification Number 00443832 00443832
Brand name DEPAKENE DEPAKENE
Common or Proper name VALPROIC ACID VALPROIC ACID
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients VALPROIC ACID VALPROIC ACID
Strength(s) 250MG 250MG
Dosage form(s) SOLUTION SOLUTION SOLUTION SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 240ML 240ML
ATC code N03AG N03AG
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-07-15 2024-07-03
Actual start date 2024-07-12
Estimated end date 2024-08-02 2024-07-16
Actual end date 2024-08-06
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments